Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
暂无分享,去创建一个
C. Porta | G. Muto | R. Montironi | P. Marchetti | B. Vincenzi | G. Tonini | S. Buti | R. Berardi | G. Di Lorenzo | S. Cascinu | F. Massari | U. de Giorgi | M. Santoni | D. Santini | R. Papalia | G. Procopio | M. Maruzzo | E. Verzoni | A. Conti | L. Burattini | R. Ricotta | L. Galli | E. Altobelli | E. Biasco | D. De Lisi | M. Nicodemo
[1] A. Poprach,et al. Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis. , 2016, European urology.
[2] F. Montorsi,et al. Conditional survival after radical nephroureterectomy for upper tract carcinoma. , 2015, European urology.
[3] A. Masson-Lecomte,et al. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. , 2014, European urology.
[4] A. Palazzo,et al. Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials. , 2014, Cancer treatment reviews.
[5] M. Eto,et al. Complete remission with tyrosine kinase inhibitors in renal cell carcinoma , 2012, Translational andrology and urology.
[6] D. Hosmer,et al. Interpretation of a Fitted Proportional Hazards Regression Model , 2011 .
[7] T. Gentile,et al. Treatment options for metastatic renal cell carcinoma: a review. , 2008, The Canadian journal of urology.
[8] David W. Hosmer,et al. Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .
[9] J. Olsen,et al. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M Mazumdar,et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[12] M. Karno,et al. Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.